看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 35.8x - 39.5x | 37.7x |
| Selected Fwd P/E Multiple | 23.1x - 25.5x | 24.3x |
| Fair Value | €158.37 - €175.04 | €166.70 |
| Upside | -6.5% - 3.3% | -1.6% |
| Benchmarks | - | Full Ticker |
| Bio-Techne Corporation | - | NasdaqGS:TECH |
| Revvity, Inc. | - | NYSE:RVTY |
| Thermo Fisher Scientific Inc. | - | NYSE:TMO |
| Mesa Laboratories, Inc. | - | NasdaqGS:MLAB |
| Azenta, Inc. | - | NasdaqGS:AZTA |
| Danaher Corporation | - | DB:DAP |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| TECH | RVTY | TMO | MLAB | AZTA | DAP | |||
| NasdaqGS:TECH | NYSE:RVTY | NYSE:TMO | NasdaqGS:MLAB | NasdaqGS:AZTA | DB:DAP | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 11.9% | 4.4% | 11.4% | NM- | NM- | 10.5% | ||
| 3Y CAGR | 6.2% | -31.7% | -6.4% | NM- | NM- | -9.6% | ||
| Latest Twelve Months | -35.1% | 41.2% | 5.9% | 99.8% | -516.7% | -15.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 20.6% | 19.1% | 16.7% | -21.7% | 81.1% | 20.7% | ||
| Prior Fiscal Year | 25.1% | 6.5% | 14.0% | -117.6% | -1.9% | 17.6% | ||
| Latest Fiscal Year | 14.5% | 10.3% | 14.8% | -0.8% | -25.0% | 16.3% | ||
| Latest Twelve Months | 10.9% | 10.0% | 15.2% | -0.3% | -25.1% | 14.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 27.2x | 14.9x | 18.3x | 12.8x | 53.4x | 20.7x | ||
| Price / LTM Sales | 6.5x | 3.6x | 3.9x | 1.4x | 1.9x | 5.8x | ||
| LTM P/E Ratio | 59.4x | 36.3x | 25.7x | -550.2x | -7.8x | 41.0x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -550.2x | 25.7x | 59.4x | |||||
| Historical LTM P/E Ratio | 29.1x | 41.7x | 51.2x | |||||
| Selected P/E Multiple | 35.8x | 37.7x | 39.5x | |||||
| (x) LTM Net Income | 3,413 | 3,413 | 3,413 | |||||
| (=) Equity Value | 122,077 | 128,502 | 134,927 | |||||
| (/) Shares Outstanding | 716.1 | 716.1 | 716.1 | |||||
| Implied Value Range | 170.49 | 179.46 | 188.43 | |||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 146.06 | 153.74 | 161.43 | 169.42 | ||||
| Upside / (Downside) | -13.8% | -9.3% | -4.7% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | TECH | RVTY | TMO | MLAB | AZTA | DAP | |
| Value of Common Equity | 7,818 | 10,125 | 169,525 | 341 | 1,300 | 141,606 | |
| (/) Shares Outstanding | 156.8 | 117.9 | 377.6 | 5.5 | 45.8 | 716.1 | |
| Implied Stock Price | 49.87 | 85.90 | 448.94 | 62.01 | 28.40 | 197.76 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 49.87 | 85.90 | 448.94 | 62.01 | 28.40 | 169.42 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |